FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

1521841000168100: glucose 150 g / 1.54 L injection, 790 mL chamber (medicinal product unit of use)

Status: current, Defined. Date: 31-Jan 2021. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4516951000168117 glucose 150 g / 1.54 L injection, 790 mL chamber (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4516961000168115 glucose 150 g/1.54 L injection, 790 mL chamber en Synonym Active Case sensitive Australian Medicines Terminology module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
glucose 150 g/1.54 L injection, 790 mL chamber Is a glucose true Inferred relationship Some
glucose 150 g/1.54 L injection, 790 mL chamber Is a medicinal product unit of use true Inferred relationship Some
glucose 150 g/1.54 L injection, 790 mL chamber has manufactured dose form injection true Inferred relationship Some
glucose 150 g/1.54 L injection, 790 mL chamber has intended active ingredient glucose true Inferred relationship Some 1611814720
glucose 150 g/1.54 L injection, 790 mL chamber has Australian BoSS glucose true Inferred relationship Some 1611814720
glucose 150 g/1.54 L injection, 790 mL chamber has unit of use chamber true Inferred relationship Some 1595725962
Inbound Relationships Type Active Source Characteristic Refinability Group
Kabiven G19% Glucose 150 g/1.54 L injection, 790 mL chamber Is a True glucose 150 g/1.54 L injection, 790 mL chamber Inferred relationship Some
glucose 150 g/1.54 L injection [790 mL chamber] (&) alanine 7.2 g/1.54 L + arginine 5.1 g/1.54 L + aspartic acid 1.5 g/1.54 L + glutamic acid 2.5 g/1.54 L + glycine 3.6 g/1.54 L + histidine 3.1 g/1.54 L + isoleucine 2.5 g/1.54 L + leucine 3.6 g/1.54 L + lysine hydrochloride 5.1 g/1.54 L + methionine 2.5 g/1.54 L + phenylalanine 3.6 g/1.54 L + proline 3.1 g/1.54 L + serine 2 g/1.54 L + threonine 2.5 g/1.54 L + tryptophan 860 mg/1.54 L + tyrosine 100 mg/1.54 L + valine 3.3 g/1.54 L + calcium chloride dihydrate 440 mg/1.54 L + sodium glycerophosphate 2.3 g/1.54 L + magnesium sulfate heptahydrate 1.5 g/1.54 L + potassium chloride 2.7 g (potassium 36 mmol)/1.54 L + sodium acetate trihydrate 3.7 g/1.54 L injection [450 mL chamber] (&) soya oil 60 g/1.54 L injection [300 mL chamber], 4 x 1.54 L multi-chamber bags has MPUU True glucose 150 g/1.54 L injection, 790 mL chamber Inferred relationship Some 597234415
glucose 150 g/1.54 L injection [790 mL chamber] (&) alanine 7.2 g/1.54 L + arginine 5.1 g/1.54 L + aspartic acid 1.5 g/1.54 L + glutamic acid 2.5 g/1.54 L + glycine 3.6 g/1.54 L + histidine 3.1 g/1.54 L + isoleucine 2.5 g/1.54 L + leucine 3.6 g/1.54 L + lysine hydrochloride 5.1 g/1.54 L + methionine 2.5 g/1.54 L + phenylalanine 3.6 g/1.54 L + proline 3.1 g/1.54 L + serine 2 g/1.54 L + threonine 2.5 g/1.54 L + tryptophan 860 mg/1.54 L + tyrosine 100 mg/1.54 L + valine 3.3 g/1.54 L + calcium chloride dihydrate 440 mg/1.54 L + sodium glycerophosphate 2.3 g/1.54 L + magnesium sulfate heptahydrate 1.5 g/1.54 L + potassium chloride 2.7 g (potassium 36 mmol)/1.54 L + sodium acetate trihydrate 3.7 g/1.54 L injection [450 mL chamber] (&) soya oil 60 g/1.54 L injection [300 mL chamber], 1.54 L multi-chamber bag has MPUU True glucose 150 g/1.54 L injection, 790 mL chamber Inferred relationship Some 1954742352

Reference Sets

Medicinal product unit of use reference set

Back to Start